EQT VIII targets primarily control equity investments as well as significant influence investments in companies with strong market positions, significant potential for revenue and earnings growth, strong cash flows and a solid platform that can retain and attract high-quality management. EQT VIII will seek to make equity investments typically ranging between EUR 150 million and EUR 1,000 million. The geographical focus will primarily be Northern Europe and the fund will mainly focus on investments in the Healthcare, TMT and Services sectors.

Commitments by region

Commitments by type


(Rotate device to see the full table)
Company Sector Country Entry Exit
Facile TMT Italy Jun 2018
Banking Circle TMT Denmark Oct 2018
Azelis Services Luxembourg Nov 2018
Cast & Crew TMT, Services United States Dec 2018
SUSE TMT Germany Mar 2019
Karo Pharma Healthcare Sweden Jan 2019
Igenomix Healthcare Spain Jun 2019
Dellner Couplers Industrial Technology Sweden Jun 2019
Galderma Healthcare Switzerland Oct 2019
Aldevron Healthcare United States Oct 2019
Waystar TMT United States Oct 2019
WS Audiology Healthcare Denmark Feb 2019